Exact FDA event identifier

Event 71984

7 recalled-product records grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: August 13, 2015
Product types: Drug
Classifications: Class III
Statuses: Terminated
Recalling firm wording: Dr. Reddy's Laboratories, Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

7 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 7

Amlodipine besylate and Atorvastatin calcium Tablets, 2.5 mg/10 mg, 30 Count Bottles, Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India. NDC: 43598-323-30.

D-1373-2015

Recall number: D-1373-2015
Initiated: August 13, 2015
Classification: Class III
Status: Terminated
Recalling firm: Dr. Reddy's Laboratories, Inc.
Quantity: 1,056 Bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug: Subpotent atorvastatin.

Code information

Lot #: C403575, Expiry: 10/2015

Distribution pattern

U.S. Nationwide

drug · product 2 of 7

Amlodipine besylate and Atorvastatin calcium Tablets, 2.5 mg/20 mg, 30 Count Bottles, Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India. NDC: 43598-320-30.

D-1374-2015

Recall number: D-1374-2015
Initiated: August 13, 2015
Classification: Class III
Status: Terminated
Recalling firm: Dr. Reddy's Laboratories, Inc.
Quantity: 576 Bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug: Subpotent atorvastatin.

Code information

Lot #: C403574, Expiry: 10/2015

Distribution pattern

U.S. Nationwide

drug · product 3 of 7

Amlodipine besylate and Atorvastatin calcium Tablets,2.5 mg/40 mg, 30 Count Bottles, Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India. NDC: 43598-317-30.

D-1375-2015

Recall number: D-1375-2015
Initiated: August 13, 2015
Classification: Class III
Status: Terminated
Recalling firm: Dr. Reddy's Laboratories, Inc.
Quantity: 984 Bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug: Subpotent atorvastatin.

Code information

Lot #: C402341, Expiry: 08/2015

Distribution pattern

U.S. Nationwide

drug · product 4 of 7

Amlodipine besylate and Atorvastatin calcium Tablets, 5 mg/20 mg, Packaged in a) 30 Count Bottles (NDC: 43598-319-30) and b) 90 Count Bottles (NDC: 43598-319-90), Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India.

D-1376-2015

Recall number: D-1376-2015
Initiated: August 13, 2015
Classification: Class III
Status: Terminated
Recalling firm: Dr. Reddy's Laboratories, Inc.
Quantity: a) 14,640 and b) 624 Bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug: Subpotent atorvastatin.

Code information

a) Lot #: C403577, Expiry: 10/2015; b) Lot #: C403577, Expiry: 10/2015.

Distribution pattern

U.S. Nationwide

drug · product 5 of 7

Amlodipine besylate and Atorvastatin calcium Tablets, 10 mg/20 mg, Packaged in a) 30 Count Bottles (NDC: 43598-318-30) and b) 90 Count Bottles (NDC: 43598-318-90), Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India

D-1377-2015

Recall number: D-1377-2015
Initiated: August 13, 2015
Classification: Class III
Status: Terminated
Recalling firm: Dr. Reddy's Laboratories, Inc.
Quantity: a) 16,080 and b) 480 Bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug: Subpotent atorvastatin.

Code information

a) Lot #: C404592, Expiry: 11/2015. b) Lot #: C404592, Expiry: 11/2015

Distribution pattern

U.S. Nationwide

drug · product 6 of 7

Amlodipine besylate and Atorvastatin calcium Tablets,10 mg/40 mg, Packaged in a) 30 Count Bottles (NDC: 43598-315-30) and b) 90 Count Bottles (NDC: 43598-315-90), Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India.

D-1378-2015

Recall number: D-1378-2015
Initiated: August 13, 2015
Classification: Class III
Status: Terminated
Recalling firm: Dr. Reddy's Laboratories, Inc.
Quantity: a) 16,848 and b) 216 Bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug: Subpotent atorvastatin.

Code information

a) Lot #: C409650, Expiry: 05/2016; Lot #: C409652,Expiry: 05/2016. b) Lot #: C409652, Expiry: 05/2016

Distribution pattern

U.S. Nationwide

drug · product 7 of 7

Amlodipine besylate and Atorvastatin calcium Tablets, 10 mg/80 mg, 30 Count Bottles, Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India. NDC: 43598-313-30.

D-1379-2015

Recall number: D-1379-2015
Initiated: August 13, 2015
Classification: Class III
Status: Terminated
Recalling firm: Dr. Reddy's Laboratories, Inc.
Quantity: 3840 Bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug: Subpotent atorvastatin.

Code information

Lot #: C404595, Expiry: 11/2015

Distribution pattern

U.S. Nationwide